School: Ohio State University, Fisher College of Business
Team members: Bradley G. Beasecker, H. Lee Mosbacker, Michael Hetzer, Arthur J. Epstein, John D. Bair, Phil Smith, Matt Carbonara
Concept: According to the American Cancer Society, one in eight American women will be diagnosed with breast cancer at some point in their lives. More than 35 million mammograms were performed in the U.S. last year. Headed by scientists and venture capitalists, Traycer Diagnostic Systems (TDS) promises less invasive, less painful breast cancer screening and diagnosis based on imaging technologies that can identify cancer cells based on their chemical signatures.
Using patented technologies developed at Ohio State University, TDS hopes to create diagnostic imaging machines that can scan and detect breast tumors more accurately and cheaply than current analog and digital mammography systems. In theory this should reduce the need for costly and invasive biopsies.
Timeline: TDS hopes to have a product on the market in about three years, allowing reasonable time for R&D and FDA approval. - Jennifer Lawinski
NEXT: Counterfeiters beware